MedTrace Logo

The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort

NCT01723709 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 973

Last updated 2017-07-21

No results posted yet for this study

Summary

The goal of this study is to enroll 1000 participants with a history of Multiple Sclerosis into the MURDOCK Study (Duke IRB Pro00011196) as well as into the Multiple Sclerosis Cohort study (Duke IRB Pro00023791). All 1000 participants will answer a 4-page questionnaire administered by a trained study coordinator which is designed to collect information on the participant's diagnosis of Multiple Sclerosis. The goal of the study is to seek genetic explanations for response to treatment, progression of the disease, and biomarker validation.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Simon Gregory, PhD · Duke Medicine Site Based Research Group

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01723709 on ClinicalTrials.gov